The tuberculin skin test still matters for the screening of latent Tuberculosis infections among Inflammatory Bowel Disease patients

Our results underscore the need to maintain the TST on LTBI diagnosis in patients about to start or switch anti-TNFα therapy in an intermediate Tuberculosis incidence context.